Development of a novel lipidic nanoparticle probe using liposomal encapsulated Gd2O3-DEG for molecular MRI

Journal of Microencapsulation

Volumn 30, Issue 7, 2013, Pages 613-623

  Zohdiaghdam, R ^a   Riyahi Alam, N ^a   Moghimi, H R ^b   Haghgoo, S ^c   Alinaghi, A ^d   Azizian, Gh ^a   Ghanaati, H ^d   Gorji, E ^b   Rafiei, B ^e  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c MINISTRY OF HEALTH AND MEDICAL EDUCATION   (Iran)

^d TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cell lines; Contrast agents; Encapsulation; Gd nanoparticle; Paramagnetic liposomes

Indexed keywords

DIETHYLENE GLYCOL; GADOLINIUM; GADOLINIUM OXIDE DIETHYLENE GLYCOL COMPLEX; GADOLINIUM PENTETATE; LIPOSOME; NANOPARTICLE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTRAST ENHANCEMENT; DRUG SYNTHESIS; DRUG UPTAKE; LIPID COMPOSITION; MOLECULAR IMAGING; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PARTICLE SIZE; TRANSMISSION ELECTRON MICROSCOPY;

ANIMALS; CELL LINE; CONTRAST MEDIA; ETHYLENE GLYCOLS; GADOLINIUM; LIPOSOMES; MAGNETIC RESONANCE IMAGING; MICE; NANOPARTICLES;

EID: 84885358039     PISSN: 02652048     EISSN: 14645246     Source Type: Journal    
DOI: 10.3109/02652048.2013.770095     Document Type: Article

References (37)

1. Artemov D. Molecular magnetic resonance imaging with targeted contrast agents. J Cell Biochem, 2003;90:518-24.
2. Casula M, Corrias A, Arosio P, Lascialfari A, Sen T, Floris P, Bruce IJ. Design of water-based ferrofluids as contrast agents for magnetic resonance imaging. J Colloid Interface Sci, 2011;357:50-5.
3. Casula M, Floris P, Innocenti C, Lascialfari A, Marinone M, Corti M, Sperling RA, Parak WJ, Sangregorio C. Magnetic resonance imaging contrast agents based on Iron oxide superparamagnetic ferrofluids. Chem Mater, 2010;22:1739-48.
4. De Cuyper M, Soenen SJH, Coenegrachts K, Ter Beek L. Surface functio-nalization of magnetoliposomes in view of improving iron oxide-based magnetic resonance imaging contrast agents: Anchoring of gadolinium ions to a lipophilic chelate. Anal Biochem, 2007;367:266-73.
5. Faucher L, Gossuin Y, Fortin MA. Impact of agglomeration on the relaxo-metric properties of gadolinium oxide nanoparticles. Nanotechnology, 2011a;22:295103.
6. Faucher L, Guay-Bégin AA, Lagueux J, Côté MF, Petitclerc E, Fortin MA. Ultra-small gadolinium oxide nanoparticles to image brain cancer cells in vivo with MRI. Contrast Media Mol Imaging, 2011b;6:209-18.
7. 3 nanoparticles for positive contrast at 1.5 T magnetic resonance clinical scanning. Nanotechnology, 2007;18:1-9.
8. Ghaghada K, Hawley C, Kawaji K, Annapragada A, Mukundan JS. T1 relax-ivity of core-encapsulated gadolinium liposomal contrast agents effect of liposome size and internal gadolinium concentration. Acad Radiol, 2008;15:1259-63.
9. Gløgard CH, Stensrud G, Aime S. Novel radical-responsive MRI contrast agent based on paramagnetic liposomes. Magn Reson Chem, 2003;41: 585-8.
10. 3 nanoparticles in hematopoietic cells for MRI contrast enhancement. Int J Nanomedicine, 2011;6:3233-40.
11. Hengerer A, Grimm J. Molecular magnetic resonance imaging. Biomed Imaging Interv J, 2006;2:1-7.
12. 2. Biochem Biophys Res Commun, 1998;245:705-8.
13. 3 nanoparticles. Contrast Media Mol Imaging, 2008;3:106-11.
14. Kontogiannopoulos KN, Assimopoulou AN, Dimas K, Papageorgiou VP. Shikonin-loaded liposomes as a new drug delivery system: Physicochemical characterization and in vitro cytotoxicity. Eur J Lipid Sci Tech, 2011;113:1113-23.
15. Kontogiannopoulos KN, Assimopoulou AN, Hatziantoniou S, Karatasos K, Demetzos C, Papageorgiou VP. Chimeric advanced drug delivery nano systems (chi-aDDnSs) for shikonin combining dendritic and liposomal technology. Int J Pharm, 2012;422:381-9.
16. Kozlowska D, Foran P, MacMahon P, Shelly M, Eustace S, O'Kennedy R. Molecular and magnetic resonance imaging: The value of immunolipo-somes. Adv Drug Deliv Rev, 2009;61:1402-11.
17. Krishnan KM. Biomedical nanomagnetics: A spin through possibilities in imaging, diagnostics, and therapy. IEEE Trans Magn, 2010;46:2523-58.
18. Kuo P. Gadolinium-containing MRI contrast agents: Important variations on a theme for NSF. J Am Coll Radiol, 2008;5:29-35.
19. Kuriashkin I, Losonsky J. Contrast enhancement in magnetic resonance imaging using intravenous paramagnetic contrast media: A review. Vet Radiol Ultrasound, 2000;41:4-7.
20. Lauffer RB. Paramagnetic metal complexes as water proton relaxation agents for NMR imaging: Theory and design. Chem Rev, 1987;87:901-27.
21. Laurent S, Elst LV, Muller RN. Comparative study of the physicochemical properties of six clinical low molecular weight gadolinium contrast agents. Contrast Med Mol Imaging, 2006;1:128-37.
22. Liu Y, Chen Z, Zhang N. Novel nanovectors as liver targeting MRI contrast agents. J Chin Pharmaceut Sci, 2011;20:105-17.
23. Oliver M, Ahmad A, Kamaly N, Perouzel E, Caussin A, Keller M, Herlihy A, Bell J, Miller AD, Jorgensen MR. MAGfect: A novel liposome formulation for MRI labelling and visualization of cells. Org Biomol Chem, 2006;18: 3489-97.
24. Oussoren C, Eling W, Crommelin D, Storm G, Zuidema J. The influence of the route of administration and liposome composition on the potential of liposomes to protect tissue against local toxicity of two antitumor drugs. Biochim Biophys Acta, 1998;1369:159-72.
25. Paradissis A, Hatziantoniou S, Georgopoulos A, Demetzos C. Lipid analysis of Greek broad bean oil: Preparation of liposomes and physicochemical characterization. Eur J Lipid Sci Technol, 2005;107:799-804.
26. Park JY, Choi ES, Baek MJ, Lee GH, Woo S, Chang Y. Water-soluble ultra small paramagnetic or superparamagnetic metal oxide nanoparticles for molecular MR imaging. Eur J Inorg Chem, 2009;17:2477-81.
27. 3 nanocrystals and organicmolecules-An experimental and quantum-chemicalstudy. Surf Sci, 2005;592:124-40.
28. Prijic S, Sersa G. Magnetic nanoparticles as targeted deliverysystems in oncology. Radiol Oncol J, 2011;45:1-16.
29. 3 nanoparticles as a positive MRI contrast agent for cell uptake. IEEE Conference Biomedical Engineering (ICBME) 17th Iranian Conference, Isfahan, pp. 1-4.
30. Riyahi-Alam N, Behrouzkia Z, Seifalian A, Haghgoo S. Properties evaluation of a new MRI contrast agent based on Gd-Loaded nanoparticles. Biol Trace Elem Res, 2010b;137:324-34.
31. Roberts D, Zhu WL, Frommen CM, Rosenzweig Z. Synthesis of gadolinium oxide magnetoliposomes for magnetic resonance imaging. Appl Phys J, 2000;87:6208-10.
32. Seymour LW. Passive tumor targeting of soluble macromolecules and drug conjugates. Crit Rev Ther Drug Carrier Syst, 1992;9:135-87.
33. Soenen SJ, Velde GV, Ketkar-Atre A, Himmelreich U, Cuyper MD. Magnetoliposomes as magnetic resonance imaging contrast agents. Nanomed Nanobiotechnol J, 2011;3:197-211.
34. Strijkers GJ, Mulder WJM, Heeswijk RBV, Frederik PM, Bomans P, Magusin PC, Nicolay K. Relaxivity of liposomal paramagnetic MRI contrast agents. MAGMA, 2005;18:186-92.
35. Takano S, Aramaki Y, Tsuchiya S. Physicochemical properties of liposomes affecting apoptosis induced by cationic liposomes in macrophages. Pharm Res, 2003;20:962-8.
36. Tilcock C, Unger E, Cullis P, MacDougall P. Liposomal Gd-DTPA: Preparation and characterization of relaxivity. Vet Radiol Ultrasound, 1989;171:77-80.
37. Yadav AV, Murthy MS, Shete AS, Sfurti S. Stability aspects of liposomes. Ind J Pharm Edu Res, 2011;45:402-13.